Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jeffery Jorgensen"'
Autor:
Naval Daver, Hagop Kantarjian, Guillermo Garcia-Manero, Elias Jabbour, Gautam Borthakur, Mark Brandt, Sherry Pierce, Kenneth Vaughan, Jing Ning, Graciela M. Nogueras González, Keyur Patel, Jeffery Jorgensen, Naveen Pemmaraju, Tapan Kadia, Marina Konopleva, Michael Andreeff, Courtney DiNardo, Jorge Cortes, Renee Ward, Adam Craig, Farhad Ravandi
Publikováno v:
Haematologica, Vol 102, Iss 10 (2017)
Vosaroxin is an anti-cancer quinolone-derived DNA topoisomerase II inhibitor. We investigated vosaroxin with decitabine in patients ≥60 years of age with newly diagnosed acute myeloid leukemia (n=58) or myelodysplastic syndrome (≥10% blasts) (n=7
Externí odkaz:
https://doaj.org/article/ec940b587bf2478fbb22e246c35b5afc
Autor:
Naveen Pemmaraju, Keyur P. Patel, Elias Jabbour, Jeffery Jorgensen, Renee Ward, Michael Andreeff, Jing Ning, Naval Daver, Marina Konopleva, Hagop M. Kantarjian, Tapan M. Kadia, Jorge E. Cortes, Farhad Ravandi, Adam R. Craig, Sherry Pierce, Guillermo Garcia-Manero, Graciela M. Nogueras González, Kenneth Vaughan, Courtney D. DiNardo, Mark Brandt, Gautam Borthakur
Publikováno v:
Haematologica
Vosaroxin is an anti-cancer quinolone-derived DNA topoisomerase II inhibitor. We investigated vosaroxin with decitabine in patients ≥60 years of age with newly diagnosed acute myeloid leukemia (n=58) or myelodysplastic syndrome (≥10% blasts) (n=7
Publikováno v:
The Laryngoscope. 119:2141-2149
Objectives/Hypothesis: To compare the efficacy of acellular dermal matrix (ADM) and split thickness skin grafts (STSG) in oral cavity reconstruction. Study Design: Prospective cohort study. Methods: Thirty-four patients were included in this study (A
Publikováno v:
The Laryngoscope. 119(11)
To compare the efficacy of acellular dermal matrix (ADM) and split thickness skin grafts (STSG) in oral cavity reconstruction.Prospective cohort study.Thirty-four patients were included in this study (ADM, n = 22; STSG, n = 12). Evaluation for patien